Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
3.040
+0.030 (1.00%)
Nov 4, 2024, 4:00 PM EST - Market closed
Trevi Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Trevi Therapeutics stock have an average target of 9.13, with a low estimate of 6.00 and a high estimate of 21. The average target predicts an increase of 200.33% from the current stock price of 3.04.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TRVI stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 4 | 4 | 5 | 5 |
| Buy | 1 | 1 | 2 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 6 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +97.37% | Oct 22, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +590.79% | Oct 21, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +97.37% | Oct 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +163.16% | Oct 4, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $21 | Strong Buy | Maintains | $21 | +590.79% | Oct 4, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.48
from -0.29
EPS Next Year
-0.49
from -0.48
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 6.2M | ||
| Avg | n/a | n/a | 668,671 | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.42 | -0.43 | -0.26 | ||
| Avg | -0.48 | -0.49 | -0.54 | ||
| Low | -0.49 | -0.59 | -0.69 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.